08048035996
Imatib 400mg Tablet Good Quality to UK - Liverpool | Phoenix Exim | Trusted Exporter

1. General Information

Imatib 400 mg Tablet is an oral targeted anticancer medicine containing Imatinib Mesylate. It belongs to the tyrosine kinase inhibitor (TKI) class. Unlike conventional chemotherapy, imatinib is designed to target particular abnormal proteins that contribute to cancer-cell growth.

It is commonly prescribed for certain forms of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GIST), and other specific conditions depending on the patient's diagnosis and molecular characteristics.

Manufacturer: Cipla Ltd.
Active ingredient: Imatinib Mesylate
Strength: 400 mg
Dosage form: Film-coated oral tablet
Prescription status: Prescription medicine


2. Product Information

Product DetailInformation
BrandImatib 400 mg
Generic nameImatinib
CompositionImatinib Mesylate equivalent to Imatinib 400 mg
Drug classTyrosine Kinase Inhibitor
Dosage formTablet
RouteOral
ManufacturerCipla Ltd.
Typical pack10 tablets per strip
PrescriptionRequired

The exact dose, treatment duration and frequency depend on the type and stage of disease, response to treatment, other medicines being used and the patient's overall health.


3. Uses of Imatib 400 mg Tablet

Imatib 400 mg may be prescribed for specific indications including:

  • Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML)
  • Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)
  • Gastrointestinal Stromal Tumors (GIST)
  • Dermatofibrosarcoma Protuberans (DFSP)
  • Certain myelodysplastic/myeloproliferative diseases
  • Hypereosinophilic syndrome (HES)
  • Chronic eosinophilic leukemia (CEL)
  • Aggressive systemic mastocytosis (ASM) in appropriate patients

The approved indications can vary by country and patient characteristics, so treatment should be determined by the prescribing oncologist.


4. Benefits of This Medicine

When appropriately prescribed for an indicated condition, Imatib 400 mg can:

  • Help control the growth of abnormal cancer cells.
  • Target specific cancer-driving proteins rather than broadly affecting rapidly dividing cells.
  • Help control certain forms of CML and Ph+ ALL.
  • Help slow or control the progression of GIST in appropriate patients.
  • Provide a targeted treatment option for certain cancers with specific molecular abnormalities.
  • Support long-term disease control when taken consistently according to the oncologist's treatment plan.

5. Side Effects of Imatib 400 mg

Possible side effects include:

  • Fluid retention or edema
  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Muscle cramps
  • Musculoskeletal pain
  • Fatigue
  • Rash
  • Headache
  • Dizziness
  • Weight gain
  • Cough
  • Changes in taste
  • Blurred vision

Some side effects can be serious. Unusual bleeding, severe swelling, significant breathing difficulty, rapid weight gain, severe weakness, or other concerning symptoms should be reported promptly to a healthcare professional.


6. Common Side Effects

The more frequently reported effects include:

  1. Nausea
  2. Vomiting
  3. Diarrhea
  4. Muscle cramps
  5. Musculoskeletal pain
  6. Edema/swelling
  7. Rash
  8. Fatigue
  9. Abdominal discomfort
  10. Headache
  11. Dizziness
  12. Weight gain

Not every patient experiences these effects, and their severity can vary. Regular medical follow-up helps identify and manage treatment-related problems.


7. How to Use Imatib 400 mg

  • Take Imatib exactly as prescribed by your oncologist.
  • It is generally taken with food and a full glass of water to reduce stomach irritation.
  • Swallow the tablet as directed; do not change the prescribed dose yourself.
  • Take it at approximately the same time each day if your doctor has prescribed a once-daily schedule.
  • Do not stop treatment suddenly unless instructed by your doctor.
  • If you miss a dose, follow your doctor's instructions rather than taking an extra dose on your own.
  • The duration of treatment depends on the disease and response to therapy.

Important: Imatinib dosing is disease-specific. A 400 mg strength does not mean every patient should take 400 mg daily.


8. How Imatib 400 mg Works

Imatinib is a tyrosine kinase inhibitor. Certain cancers are driven by abnormal signaling proteins that continuously tell cells to grow and multiply.

Imatinib blocks specific tyrosine kinases, including BCR-ABL in Philadelphia chromosome-positive leukemia and KIT (c-KIT) in many GIST cases. By interfering with these growth signals, it can inhibit abnormal cell proliferation and promote cancer-cell death.


9. Safety Advice

Pregnancy

Imatinib can cause harm to an unborn baby and should generally be avoided during pregnancy unless the treating physician determines that treatment is essential. Discuss contraception and pregnancy planning with your doctor.

Breastfeeding

Breastfeeding is generally not recommended during imatinib treatment because the medicine can pass into breast milk and may potentially harm the infant.

Liver

Patients with liver disease may require closer monitoring and, depending on the circumstances, dose adjustment.

Kidney

Tell your doctor about kidney disease before treatment. Renal function may need to be monitored.

Blood Counts

Doctors may perform regular blood tests to monitor blood-cell counts during treatment.

Liver Function

Regular liver-function monitoring may also be recommended.

Drug Interactions

Tell your doctor about all prescription medicines, OTC medicines, vitamins and supplements because imatinib can interact with other medicines.

Driving

Imatinib may cause dizziness, fatigue or visual disturbances in some patients. Avoid driving or operating machinery if these symptoms affect you.

Prescription Requirement

Imatib 400 mg is a prescription anticancer medicine and should only be supplied and used in accordance with applicable medical and pharmaceutical regulations.


10. Frequently Asked Questions (FAQs)

Q1. What is Imatib 400 mg Tablet?
Imatib 400 mg is an oral anticancer medicine containing imatinib. It belongs to the tyrosine kinase inhibitor class.

Q2. What is Imatib 400 mg used for?
It is used for specific cancers and blood disorders, including certain forms of CML, Ph+ ALL, GIST and DFSP.

Q3. Is Imatib 400 mg a chemotherapy medicine?
It is an anticancer medicine but is more specifically classified as a targeted tyrosine kinase inhibitor rather than conventional cytotoxic chemotherapy.

Q4. Can I take Imatib 400 mg without a prescription?
No. It should be taken only under appropriate medical supervision.

Q5. Can Imatib 400 mg cure cancer?
Its purpose depends on the particular cancer and treatment setting. It can provide substantial disease control in appropriate patients, but whether it can produce remission or long-term control depends on the disease and individual response.

Q6. Should Imatib 400 mg be taken with food?
It is generally recommended to take imatinib with food and a large glass of water, according to the prescribing instructions.

Q7. Can I stop Imatib when I feel better?
No. Do not discontinue treatment without discussing it with your oncologist.

Q8. What happens if I miss a dose?
Follow the missed-dose instructions provided by your healthcare professional. Do not take a double dose unless specifically instructed.

Q9. Does Imatib 400 mg cause swelling?
Yes. Edema or fluid retention is a recognized adverse effect. Rapid or significant swelling or weight gain should be reported to your doctor.

Q10. Does Imatib require regular blood tests?
Yes. Doctors commonly monitor blood counts and liver function during treatment to identify possible treatment-related complications.


11. Substitutes for Imatib 400 mg

Potential alternatives or brands containing imatinib 400 mg may include products such as:

  • Imat 400 mg
  • Mytinib 400 mg
  • Levin 400 mg
  • Other locally approved imatinib 400 mg brands

However, a substitute should not be selected based only on the strength. The treating oncologist or pharmacist should verify the active ingredient, manufacturer, formulation, indication and regulatory status before substitution.


12. SEO & B2B Keywords

Product Keywords

  • Imatib 400 mg Tablet
  • Imatib 400 mg tablets
  • Imatib 400 mg Imatinib tablet
  • Imatinib 400 mg tablet
  • Imatinib Mesylate 400 mg tablet
  • Imatinib 400 mg pharmaceutical supplier
  • Imatinib 400 mg medicine exporter
  • Imatib 400 mg tablet supplier
  • Imatib 400 mg wholesale supplier
  • Imatib 400 mg manufacturer supplier India

B2B Export Keywords

  • Imatib 400 mg tablet exporter from India
  • Imatib 400 mg tablet supplier from Nagpur India
  • Imatinib 400 mg exporter from India
  • Imatinib 400 mg wholesale pharmaceutical supplier
  • Imatib 400 mg international medicine supplier
  • Imatib 400 mg bulk pharmaceutical exporter
  • Imatinib 400 mg oncology medicine exporter
  • Imatib 400 mg cancer medicine supplier
  • Imatinib 400 mg B2B pharmaceutical supplier
  • Imatib 400 mg export supplier India

Country-Focused Keywords

  • Imatib 400 mg supplier to USA
  • Imatib 400 mg exporter to UK
  • Imatib 400 mg supplier to Australia
  • Imatib 400 mg exporter to Singapore
  • Imatib 400 mg supplier to Canada
  • Imatib 400 mg exporter to South Korea
  • Imatib 400 mg supplier to UAE
  • Imatinib 400 mg pharmaceutical exporter worldwide
  • Imatinib 400 mg international wholesale supplier
  • Imatib 400 mg global pharmaceutical supply
Aug 17th, 2026 3:10 PM

Keywords